{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:39:52Z","timestamp":1792100392619,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1038\/s41591-024-03052-0","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:02:27Z","timestamp":1715767347000},"page":"2337-2342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2007-343X","authenticated-orcid":false,"given":"Yael","family":"Wolff Sagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noga","family":"Ramot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Battat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6058-8665","authenticated-orcid":false,"given":"Ronen","family":"Arbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Reges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"3052_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.7326\/0003-4819-99-6-757","volume":"99","author":"FH Messerli","year":"1983","unstructured":"Messerli, F. H. et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann. Intern. Med. 99, 757\u2013761 (1983).","journal-title":"Ann. Intern. Med."},{"key":"3052_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/0735-1097(88)90467-6","volume":"12","author":"IW Hammond","year":"1988","unstructured":"Hammond, I. W., Devereux, R. B., Alderman, M. H. & Laragh, J. H. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J. Am. Coll. Cardiol. 12, 996\u20131004 (1988).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3052_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/jama.1991.03470020057032","volume":"266","author":"MS Lauer","year":"1991","unstructured":"Lauer, M. S., Anderson, K. M., Kannel, W. B. & Levy, D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA 266, 231\u2013236 (1991).","journal-title":"JAMA"},{"key":"3052_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/0002-8703(95)90210-4","volume":"130","author":"MA Alpert","year":"1995","unstructured":"Alpert, M. A. et al. Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am. Heart J. 130, 1068\u20131073 (1995).","journal-title":"Am. Heart J."},{"key":"3052_CR5","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","volume":"336","author":"RS Vasan","year":"1997","unstructured":"Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C. & Levy, D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N. Engl. J. Med. 336, 1350\u20131355 (1997).","journal-title":"N. Engl. J. Med."},{"key":"3052_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0002-9149(01)01460-6","volume":"87","author":"JM Gardin","year":"2001","unstructured":"Gardin, J. M. et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am. J. Cardiol. 87, 1051\u20131057 (2001).","journal-title":"Am. J. Cardiol."},{"key":"3052_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa020245","volume":"347","author":"S Kenchaiah","year":"2002","unstructured":"Kenchaiah, S. et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305\u2013313 (2002).","journal-title":"N. Engl. J. Med."},{"key":"3052_CR8","doi-asserted-by":"publisher","unstructured":"Drucker, D. J. Prevention of cardiorenal complications in people with type 2 diabetes and obesity. Cell Metab. https:\/\/doi.org\/10.1016\/j.cmet.2023.12.018 (2024).","DOI":"10.1016\/j.cmet.2023.12.018"},{"key":"3052_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010453","volume":"17","author":"A Mentias","year":"2024","unstructured":"Mentias, A. et al. Trends and outcomes associated with bariatric surgery and pharmacotherapies with weight loss effects among patients with heart failure and obesity. Circ. Heart Fail. 17, e010453 (2024).","journal-title":"Circ. Heart Fail."},{"key":"3052_CR10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod, M. N. et al. STEP-HFpEF Trial committees and investigators. semaglutide in patients with heart failure with preserved ejection fraction and obesity. N. Engl. J. Med. 389, 1069\u20131084 (2023).","journal-title":"N. Engl. J. Med."},{"key":"3052_CR11","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","volume":"29","author":"BA Borlaug","year":"2023","unstructured":"Borlaug, B. A. et al. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nat. Med. 29, 2358\u20132365 (2023).","journal-title":"Nat. Med."},{"key":"3052_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar, N. et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 9, 653\u2013662 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3052_CR13","doi-asserted-by":"publisher","first-page":"1092777","DOI":"10.3389\/fendo.2023.1092777","volume":"14","author":"JA Henry","year":"2023","unstructured":"Henry, J. A. et al. Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometry. Front Endocrinol. 14, 1092777 (2023).","journal-title":"Front Endocrinol."},{"key":"3052_CR14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","volume":"392","author":"AF Hernandez","year":"2018","unstructured":"Hernandez, A. F. et al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet 392, 1519\u20131529 (2018).","journal-title":"Lancet"},{"key":"3052_CR15","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/SLA.0000000000004369","volume":"272","author":"A Aminian","year":"2020","unstructured":"Aminian, A. et al. How much weight loss is required for cardiovascular benefits? Insights from a metabolic surgery matched-cohort study. Ann. Surg. 272, 639\u2013645 (2020).","journal-title":"Ann. Surg."},{"key":"3052_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11695-022-06366-5","volume":"33","author":"S Huang","year":"2023","unstructured":"Huang, S., Lan, Y., Zhang, C., Zhang, J. & Zhou, Z. The early effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. Obes. Surg. 33, 453\u2013468 (2023).","journal-title":"Obes. Surg."},{"key":"3052_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1210\/er.2018-00183","volume":"40","author":"JD Douros","year":"2019","unstructured":"Douros, J. D., Tong, J. & D\u2019Alessio, D. A. The effects of bariatric surgery on islet function, insulin secretion, and glucose control. Endocr. Rev. 40, 1394\u20131423 (2019).","journal-title":"Endocr. Rev."},{"key":"3052_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ajh\/hpx112","volume":"31","author":"JG Owen","year":"2017","unstructured":"Owen, J. G., Yazdi, F. & Reisin, E. Bariatric surgery and hypertension. Am. J. Hypertens. 31, 11\u201317 (2017).","journal-title":"Am. J. Hypertens."},{"key":"3052_CR19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/dom.14338","volume":"23","author":"JA Rassen","year":"2021","unstructured":"Rassen, J. A., Murk, W. & Schneeweiss, S. Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: a lesson in bias. Diabetes Obes. Metab. 23, 1453\u20131462 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"3052_CR20","doi-asserted-by":"crossref","unstructured":"Shkeiri, R. et al. Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: a population-based study. Respir. Med. 185, 106487 (2021).","DOI":"10.1016\/j.rmed.2021.106487"},{"key":"3052_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac, Z., Gauss, C. H., Williams, D. K. & Hosmer, D. W. Purposeful selection of variables in logistic regression. Source Code Biol. Med. 3, 17 (2008).","journal-title":"Source Code Biol. Med."},{"key":"3052_CR22","first-page":"681","volume":"120","author":"T T\u00f6nnies","year":"2023","unstructured":"T\u00f6nnies, T., Schlesinger, S., Lang, A. & Kuss, O. Mediation analysis in medical research. Dtsch Arztebl. Int. 120, 681\u2013687 (2023).","journal-title":"Dtsch Arztebl. Int."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03052-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T10:07:03Z","timestamp":1724062023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03052-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3052"],"URL":"https:\/\/doi.org\/10.1038\/s41591-024-03052-0","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.D., G.L. and O.R. reported receiving grants from the Israel Science Foundation outside the submitted work. D.D. reported receiving grants, personal fees and nonfinancial support from NovoNordisk and Eli Lilly; and personal fees and nonfinancial support from Boehringer Ingelheim outside the submitted work. The other authors declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}